http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100565022-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535
filingDate 1998-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100565022-B1
titleOfInvention Chemically Modified Polypeptides
abstract Chemically modified polypeptides in which at least one hydroxyl group of a polypeptide molecule is modified with a polyalkylene glycol derivative, a method for preparing the polypeptide, a method for treating using the polypeptide, a use of the polypeptide, the polypeptide A pharmaceutical composition containing the composition and a therapeutic composition containing the polypeptide.n n n Chemically modified polypeptides, polyalkylene glycols, human granulocyte colony stimulating factor (hG-CSF) and derivatives thereof
priorityDate 1997-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0744409-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467461681

Total number of triples: 20.